Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.
Latest posts by Market Watch (see all)
- The Conversation: Remanufacturing is a smarter way Trump can reduce the trade deficit - September 21, 2018
- NerdWallet: How to fight about money—without ruining the relationship - September 21, 2018
- NerdWallet: How much I earn is none of your business - September 21, 2018